Re: Familial Clustering of Hodgkin Lymphoma and Multiple Sclerosis
We were intrigued by the recent report of Hjalgrim et al. ( 1 ) that showed familial clustering of multiple sclerosis and young-adult-onset Hodgkin lymphoma in Denmark and that supported Newell ' s 1970 hypothesis ( 2 ) of a shared etiology. Their study and another report by Vineis et al. ( 3 ) indicate a familial association between multiple sclerosis and non-Hodgkin lymphoma.
Given the etiologic importance of these fi ndings, we wanted to evaluate this association further in the larger population of Sweden. Because there is no national multiple sclerosis registry in Sweden, unlike the situation in Denmark, we analyzed hospital discharge diagnoses of multiple sclerosis in relatives of patients with Hodgkin lymphoma and of patients with non-Hodgkin lymphoma compared with relatives of matched control subjects taken from our ongoing studies of familial aggregation of lymphoproliferative tumors. Using our hospital registry approach, we also analyzed our Danish data in the same manner and extended the sample to include relatives of patients with non-Hodgkin lymphoma.
The Swedish Family-Cancer Database has been described previously ( 4 , 5 ) . For these analyses, patients with lymphoma, control subjects, and their relatives were linked with the Swedish Hospital Discharge Register from January 1, 1964, through December 31, 2000, which contains individual-based information on discharges from inpatient care. This register has population-based (county-wise) coverage that encompassed more than 90% of the population of Sweden after the mid-1970s and 100% since 1987. We obtained information on all discharges listing multiple sclerosis (International Classifi cation of Disease [ICD], versions 7 -10) including dates of discharge. The Danish family data have been described previously ( 5 ) ; patients with lymphoproliferative disease, control subjects, and their relatives were linked with the Danish Hospital Discharge and Outpatient Registers from January 1, 1977, through December 31, 1999, as described above. The population of relatives that we identifi ed is essentially the same as that reported by Hjalgrim et al.
( 1 ) , which is expected because we used similar methodology to fi nd relatives of patients with Hodgkin lymphoma from the population databases. The numbers of patients, control subjects, and their relatives are shown for each population in Table 1 . The outcome was a recorded diagnosis of multiple sclerosis. We tested for increased risk of multiple sclerosis in relatives by using a marginal survival model with a robust variance estimate to account for familial dependencies ( 6 ) . We use relative risk (RR) to denote the hazard ratio. Risk was also computed by type of relative and by age of Hodgkin lymphoma/non-Hodgkin lymphoma onset in the proband.
Similar to the report of Hjalgrim et al.
( 1 ) , we found an increased risk of multiple sclerosis (RR = 1.98, 95% CI = 1.15 to 3.42; P = .01) when analyzing all fi rstdegree relatives of Danish patients with Hodgkin lymphoma; the highest risk was recorded in siblings (RR = 2.91, 95% CI =1.01 to 8.37; P = .05) and in relatives of a proband with young-adult-onset Hodgkin lymphoma (RR = 2.23, 95% CI = 1.23 to 4.05; P = .01) ( Table 1 ). In contrast, only a very modest and statistically non-signifi cant increase was observed in the larger Swedish population of fi rst-degree relatives of Hodgkin lymphoma probands. The highest risk was in offspring, and there was no increased risk among relatives of young adult probands. The combined sample shows a modest but statistically signifi cantly elevated risk (RR = 1.51, 95% CI =1.07 to 2.15; P = .02).
In relatives of patients with nonHodgkin lymphoma, a statistically signifi cantly increased risk of multiple sclerosis was found among fi rst-degree relatives of Danish patients (RR = 1.58, 95% CI = 1.08 to 2.32; P = .02) ( Table 1 ) , which was more prominent among relatives of young-adult-onset probands (RR = 2.06, 95% CI = 1.12 to 3.78; P = .02). In Swedish relatives of patients with non-Hodgkin lymphoma, the combined data showed a statistically significant 30% increase risk of multiple sclerosis, with the highest risk in relatives of young-adult-onset probands.
In summary, using a larger Swedish data set to evaluate the reported increased risk of multiple sclerosis in relatives of patients with Hodgkin lymphoma ( 1 ) , we found a substantially more modest, 29% statistically non-signifi cant increased risk of multiple sclerosis among fi rst-degree relatives of Swedish patients with Hodgkin lymphoma and a modest 51% increased risk in the combined sample. We also found a similarly modest, statistically non-signifi cant increased risk of multiple sclerosis among Swedish relatives of patients with non-Hodgkin lymphoma, although the 30% increased risk in the combined sample was statistically signifi cant ( P = .02). A potential limitation of our study is that the multiple sclerosis outcomes were from the hospital discharge registries and were not validated. However, because multiple sclerosis was assessed among relatives of matched control subjects with the same hospital registries, the relative risks should not be biased. This is supported by our fi nding of a similar relative risk of multiple sclerosis among relatives of Hodgkin lymphoma cases as found by Hjalgrim et al. ( 1 ) . Originally, an association between multiple sclerosis and Hodgkin lymphoma was suggested because of some ecological correlation ( 2 ) , but this was disputed by others ( 7 ) . In their report, Hjalgrim et al. ( 1 ) 
RESPONSE
In a series of analyses, we recently observed an increased risk of multiple sclerosis (relative risk [RR] = 2.25, 95% confi dence interval [CI] = 1.24 to 4.06) in fi rst-degree relatives of patients with Hodgkin lymphoma and, independently hereof, an analogously increased occurrence of young-adult Hodgkin lymphoma (RR = 1.93, 95% CI = 1.01 to 3.71) in fi rst-degree relatives of patients diagnosed with multiple sclerosis in a Danish register -based investigation ( 1 ) .
The observed clustering of these two conditions is interesting because it may refl ect that they share common risk factors and because the clustering may form the basis for new etiological Although different statistical approaches make direct comparison of risk estimates diffi cult, we agree with the authors that there is good agreement between our previous results using the Danish Multiple Sclerosis Register and the current series of analyses using Danish hospital discharge data. In our view, however, this consistency does not necessarily imply that the results of analyses of Swedish data should be interpreted uncritically. The possible implications of the various gaps in the Swedish Family Register and parental information missing for 50% of offspring dead before 1991 ( 2 ) are unclear to us, and we also disagree that diagnostic misclassifi cation in the hospital discharge data, the extent of which may well differ between Denmark and Sweden, can automatically be presumed unimportant.
With these precautions, therefore, it would seem that the most important fi nding of the current investigation is the confi rmation of the previously observed familial clustering of Hodgkin lymphoma and multiple sclerosis ( 1 ) .
HENRIK HJALGRIM KLAUS ROSTGAARD NETE MUNK NIELSEN NILS KOCH-HENRIKSEN LARS MUNKSGAARD HANS H. STORM MADS MELBYE

